Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates

被引:137
作者
Arthington-Skaggs, BA
Lee-Yang, W
Ciblak, MA
Frade, JP
Brandt, ME
Hajjeh, RA
Harrison, LH
Sofair, AN
Warnock, DW
机构
[1] CDCP, Mycot Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA
[2] Johns Hopkins Univ, Sch Hyg & Publ Hlth, Baltimore, MD USA
[3] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA
[4] Yale Univ, Sch Med, New Haven, CT USA
关键词
D O I
10.1128/AAC.46.8.2477-2481.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Visual determination of MIC end points for azole antifungal agents can be complicated by the trailing growth phenomenon. To determine the incidence of trailing growth, we performed testing of in vitro susceptibility to fluconazole and itraconazole using the National Committee for Clinical Laboratory Standards broth microdilution M27-A reference procedure and 944 bloodstream isolates of seven Candida spp., obtained through active population-based surveillance between 1998 and 2000. Of 429 C. albicans isolates, 78 (18.2%) showed trailing growth at 48 h in tests with fluconazole, and 70 (16.3%) showed trailing in tests with itraconazole. Of 118 C. tropicalis isolates, 70 (59.3%) showed trailing growth in tests with fluconazole, and 35 (29.7%) showed trailing in tests with itraconazole. Trailing growth was not observed with any of the other five Candida spp. tested (C. dubliniensis, C. glabrata, C. krusei, C. lusitaniae, and C. parapsilosis). To confirm whether or not isolates that showed trailing growth in fluconazole and/or itraconazole were resistant in vitro to these agents, all isolates that showed trailing growth were retested by the sterol quantitation method, which measures cellular ergosterol content rather than growth inhibition after exposure to azoles. By this method, none of the trailing isolates was resistant in vitro to fluconazole or itraconazole. For both agents, a 24-h visual end point or a spectrophotometric end point of 50% reduction in growth relative to the growth control after 24 or 48 h of incubation correlated most closely with the result of sterol quantitation. Our results indicate that MIC results determined by either of these end point rules may be more predictive of in vivo outcome for isolates that give unclear visual end points at 48 h due to trailing growth.
引用
收藏
页码:2477 / 2481
页数:5
相关论文
共 19 条
  • [1] Quantitation of ergosterol content:: Novel method for determination of fluconazole susceptibility of Candida albicans
    Arthington-Skaggs, BA
    Jradi, H
    Desai, T
    Morrison, CJ
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (10) : 3332 - 3337
  • [2] Quantitation of Candida albicans ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invasive candidiasis
    Arthington-Skaggs, BA
    Warnock, DW
    Morrison, CJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (08) : 2081 - 2085
  • [3] Influence of glucose supplementation and inoculum size on growth kinetics and antifungal susceptibility testing of Candida spp.
    Cuenca-Estrella, M
    Díaz-Guerra, TM
    Mellado, E
    Rodríguez-Tudela, JL
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (02) : 525 - 532
  • [4] Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study
    Diekema, DJ
    Messer, SA
    Brueggemann, AB
    Coffman, SL
    Doern, GV
    Herwaldt, LA
    Pfaller, MA
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (04) : 1298 - 1302
  • [5] COLLABORATIVE COMPARISON OF BROTH MACRODILUTION AND MICRODILUTION ANTIFUNGAL SUSCEPTIBILITY TESTS
    ESPINELINGROFF, A
    KISH, CW
    KERKERING, TM
    FROMTLING, RA
    BARTIZAL, K
    GALGIANI, JN
    VILLAREAL, K
    PFALLER, MA
    GERARDEN, T
    RINALDI, MG
    FOTHERGILL, A
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (12) : 3138 - 3145
  • [6] EVALUATION OF 80-PERCENT INHIBITION STANDARDS FOR THE DETERMINATION OF FLUCONAZOLE MINIMUM INHIBITORY CONCENTRATIONS IN 3 LABORATORIES
    ESPINELINGROFF, A
    STEELEMOORE, L
    GALGIANI, JN
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1994, 20 (02) : 81 - 86
  • [7] Optimizing voriconazole susceptibility testing of Candida:: Effects of incubation time, endpoint rule, species of Candida, and level of fluconazole susceptibility
    Lozano-Chiu, M
    Arikan, S
    Paetznick, VL
    Anaissie, EJ
    Rex, JH
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (09) : 2755 - 2759
  • [8] National Committee for Clinical Laboratory Standards, 1997, REF METH BROTH DIL A
  • [9] Influence of incubation time, inoculum size, and glucose concentrations on spectrophotometric endpoint determinations for amphotericin B, fluconazole, and itraconazole
    Nguyen, MH
    Yu, CY
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (01) : 141 - 145
  • [10] ANTIFUNGAL SUSCEPTIBILITY TESTING OF YEASTS - EVALUATION OF TECHNICAL VARIABLES FOR TEST AUTOMATION
    ODDS, FC
    VRANCKX, L
    WOESTENBORGHS, F
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (09) : 2051 - 2060